Introduction {#s1}
============

Understanding how ensembles of neurons produce behaviors is an important aim of neuroscience. The mapping of the neural circuits that underlie a behavior is considered a necessary first step toward this goal, and efforts to determine the 'connectome' of different parts of the nervous system have been present since the beginnings of modern neuroscience. They start with the classical inferred synaptic relationships in Cajal's anatomical analyses ([@bib49]), through the detailed information on the wiring of some invertebrate circuits (e.g., [@bib9]; [@bib13]; [@bib32], [@bib33]), culminating with the complete map of the *Caenorhabditis elegans* central nervous system (CNS) ([@bib62]), and the wiring diagrams of the *Drosophila* optic lobes ([@bib57]) and the mammalian retina ([@bib26]). Yet, research into the functioning of neuronal networks has revealed that a wiring diagram is usually not enough to understand what a neuronal network can do, although it does inform on its possible outcomes. One of the elements that adds tremendous multiplicity to the universe of possible outputs of a neural circuit is the action of neuromodulators, including biogenic amines and neuropeptides. In conjunction with classical transmitters, they can gate the input to a circuit or reconfigure its pattern of activity, thereby causing the same circuit to produce qualitatively different outputs ([@bib6]; [@bib5]; [@bib7]; [@bib37]; [@bib44]; [@bib47]).

The influence of neuropeptides can be profound and underlies the expression of entire behavioral states, such as hunger and satiation ([@bib2]; [@bib11]; [@bib23]), pair bonding and stress ([@bib40]; [@bib46]), and arousal and attention ([@bib39]), and can involve many brain regions in addition to sensory and physiological inputs. How these actions are effected is poorly understood because neuropeptides can be broadly released within the CNS and exert combinatorial and non-linear effects ([@bib7]). In addition, we know little about how these gatekeepers are themselves regulated, yet such knowledge is also critical for understanding how the expression of a behavioral state is controlled. Here, we report on the genetic dissection, using *Drosophila*, of the response of a network of peptidergic neurons that controls the stereotyped and sequential insect behavior of ecdysis, and which represents a tractable system in which these questions can be addressed.

Ecdysis is the vital behavior that is used by arthropods to shed the remains of the old cuticle at the end of every molt ([@bib18]). It includes several behavioral subroutines and physiological events that are expressed sequentially to loosen and then shed the old cuticle, then expand and harden the new one. In insects, it is triggered by the sudden release of the neuropeptide, Ecdysis-Triggering Hormone (ETH) ([@bib17]; [@bib16]), which activates sequentially a number of peptidergic neurons, each expressing the A isoform of the ETH receptor (ETHR) ([@bib15]; [@bib31], [@bib31]). A current model proposes that each class of peptidergic ETH targets then activates or modulates specific phases of ecdysis behavior ([@bib31]). However, the mechanism responsible for producing the sequential activation of these targets in response to a common ETH stimulus is currently unknown.

Here, we combined the use of genetically encoded calcium- and voltage-sensitive probes, targeted RNAi expression, mutants null for particular neuropeptides downstream of ETH, and pharmacology, to understand how this response is produced. For this we focused on the subset of neurons that produce CCAP (Crustacean cardioactive peptide), which play a key role in the control of ecdysis ([@bib31], [@bib31]; [@bib36]; [@bib48]). We show that the response of CCAP neurons to ETH and the ensuing ecdysis behaviors depend on direct actions mediated by the ETH trigger as well as on the actions of neuropeptides downstream of ETH together with inhibition mediated by GABA. Importantly, we found that removal of a downstream neuropeptide can eliminate the rhythmic pattern of neuronal activity induced by ETH, revealing that such neuropeptides are critical for the expression of the fundamental features of this neural response. Our findings have implications for understanding how this vital insect behavior is controlled. The principles that emerge are also relevant for understanding how peptidergic networks control behavioral states.

Results {#s2}
=======

Organization of pupal ecdysial behaviors {#s2-1}
----------------------------------------

At the end of larval life, *Drosophila* enters the prepupal stage, then ecdyses to a pupa to initiate the transformation to the adult that occurs during metamorphosis. Pupal ecdysis consists of a sequence of behavioral subroutines, which starts with the preparatory behavior of pre-ecdysis, during which the hardened larval cuticle of the puparium is loosened from the underlying pupal cuticle through slow anteriorly directed movements of the body. This phase is followed by ecdysis proper, during which alternating left-right contractions lead into a phase of anteriorly directed peristalses that eventually cause head eversion, during which the brain is pushed anterior to the mouth. During the final phase of the behavioral sequence (post ecdysis), alternating left-right contractions and then posteriorly directed movements produce a body with the external shape of an adult fly ([@bib31]; [@bib36]; [@bib48]). Each of these phases has a stereotyped duration and pattern of activity, which can be recorded in intact ([@bib31], [@bib36]; [@bib48]) and puparium-free preparations ([@bib31]; cf., Figure 2, below). In addition, fictive ecdysis can be visualized in ex vivo CNS preparations challenged with ETH that express the calcium sensor, GCaMP, in motoneurons ([Figure 1A,B](#fig1){ref-type="fig"}). Consistent with the behaviors observed at ecdysis, the pattern of motor activity expressed in vitro in response to ETH consists of an initial phase that primarily recruits activity in the posterior region of the ventral nervous system (VNS) (\'P\' region, [Figure 1Ab,Ba](#fig1){ref-type="fig"}; corresponding to pre-ecdysis) followed by a barrage of activity throughout the left and right sides of the VNS neuropils (\'L\', [Figure 1Ac; Bb](#fig1){ref-type="fig"}; and \'R\' regions, [Figure 1Ad; Bd](#fig1){ref-type="fig"}). Importantly, expansion of this latter section of the record reveals that the \'L\' and \'R\' regions are active in an alternating pattern ([Figure 1Be](#fig1){ref-type="fig"}), consistent with the prominent left-right repetitive contractions seen at ecdysis in the intact animal.10.7554/eLife.19686.003Figure 1.Fictive ecdysial behavior in normal and ETHR knockdown animals.(**A**) Snapshots of the pattern of GCaMP signal recorded from motoneurons of control animals at 0 min (**a**), 10 min (**b**), and at around 20 min (**c,d**) after in vitro challenge with 600 nM ETH. (**B**) Corresponding recording of GCaMP signal, color-coded according to regions indicated in (**Ab** and **Ac**): (**a**) \'P\' (posterior, black trace; cf., **Ab**); (**b**): \'L\' (left, blue trace; cf., **Ac**); (**c**): \'C\' (center, green trace; cf., **Ac**); (**d**) \'R\' (right, red trace; cf., **Ac**). (**e**) Expanded segment of recording (recordings for \'P\', \'L\', \'C\' and \'R\' regions superimposed) during 18--20 min period (indicated by small bar beneath time axis of (**d**)). Note the alternating activity in \'L\' and \'R\' regions. (**C**) (**a**) Motoneuron activity patterns (recordings for \'P\', \'L\', \'C\' and \'R\' regions superimposed) from animals that express ETHR RNAi in CCAP neurons; (**b**) Expanded segment of recording shown in (**a**) (recordings for \'P\', \'L\', \'C\' and \'R\' regions superimposed) during 42--48 min period (indicated by small bar beneath time axis in (**a**)). Note that \'L\' and \'R\' activity no longer alternate (compare with **Be**). Zero min indicates time of ETH challenge in all records. Genotypes: Controls (**A,B**): CCAP\>GCaMP (*Ccap*-GAL4 + UAS-GCaMP); ETHR knockdown in CCAP neurons (**C**): CCAP+MN\>GCaMP+ETHR RNAi (MN: C164 motoneuron GAL4; see Materials and methods). Note that this genotype also knocks down ETHR expression in motoneurons (MNs). Nevertheless, knockdown of ETHR only in MNs had only a slight effect on ecdysis behavior (cf. [Figure 2](#fig2){ref-type="fig"}), suggesting that most defects observed here were due to knockdown of ETHR in CCAP neurons. In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.003](10.7554/eLife.19686.003)

At the endocrine level, ecdysis is initiated by the sudden and near-complete release of ETH from peripheral epitracheal cells, which is fueled by an endocrine positive feedback with centrally produced Eclosion Hormone (EH) ([@bib17]; [@bib34]). In the CNS, direct targets of ETH include neurons that express the neuropeptides, FMRFamide (FMRF), Kinin, EH, and Crustacean Cardioactive Peptide (CCAP), either alone or in combination with bursicon (made up of two subunits, BURS and PBURS) and/or Myoinhibitory Peptides (MIPs) ([@bib15]; [@bib31]). By targeting a calcium-sensitive GFP (GCaMP) to different peptidergic ensembles, [@bib31]) showed that each of these sets of peptidergic neurons is activated at a particular time and for a specific duration following a challenge by ETH in vitro. By correlating these times with the expression of the different behavioral phases of ecdysis, each set was assigned a role in the control of particular ecdysial subroutine, which was also broadly consistent with functional and genetic evidence ([@bib15]; [@bib31], [@bib31]; [@bib35]; [@bib36]; [@bib48]). Nevertheless, the mechanisms by which the direct targets of ETH would be activated at different times after an ETH challenge remained unanswered. Here, we show that the pattern of activity of ETH targets depends on direct ETH actions, as well on actions effected by targets downstream of ETH.

Role of ETH signaling in the activation of downstream peptidergic targets {#s2-2}
-------------------------------------------------------------------------

In order to understand how the temporal pattern of activity of peptidergic ETH targets is produced, we first identified relevant neuronal sets by determining the effects on ecdysis behavior of expressing ETHR RNAi in each set of peptidergic ETH targets. Expression of ETHR RNAi in FMRFa and EH neurons caused no measurable effect on ecdysis behavior in intact ([Figure 2A](#fig2){ref-type="fig"}) or puparium-free preparations ([Figure 2B](#fig2){ref-type="fig"}) (\'FMRF\>ETHR RNAi\' and \'EH\>ETHR RNAi\', respectively), other than an increase in the frequency of pre-ecdysial contractions. The corresponding pattern of neural activity induced by ETH was not visibly altered by expression of ETHR RNAi in these neurons (not shown). In the case of EH neurons, this lack of effect could be due to their high sensitivity to ETH ([@bib31]), which could make them insensitive to the levels of reduction in ETHR expression that can be achieved by RNAi (see below). Recent work has shown that the role of kinin neurons in the control of ecdysis behavior ([@bib31]) may be mostly indirect and a consequence of its role in diuresis ([@bib15]).10.7554/eLife.19686.004Figure 2.Impact on ecdysial behaviors of manipulating ETH effectiveness on downstream targets.(**A**) Ecdysial behaviors in intact puparium. Duration of pre-ecdysis (left; open bars) and ecdysis (right; filled bars) in controls (CS and CCAP\>GCaMP), and in animals expressing ETHR RNAi in different subsets of ETH targets. (**B**) Corresponding ecdysial behaviors of puparium-free preparations. Data are mean ± SEM. In (**A**) and (**B**) duration of ecdysial phases is indicated as not significantly different ('ns\') or significantly different (\'\*\': p\<0.5; \'\*\*': p\<0.01) than those of CCAP\>GCaMP control (one-way ANOVA, Dunnett\'s *post-hoc* to control). Comparison of frequency of contractions per minute for pre-ecdysis and ecdysis (labeled *F*~pre~ and *F*~ecd~, respectively) in puparium-free preparations is indicated as not significantly different ('ns\') or significantly smaller (\'\<\': p\<0.05; \'\<\<' p\<001) or greater (\'\>\': p\<0.05; \'\>\>' p\<001) than that of CCAP\>GCaMP controls (one-way ANOVA, Dunnett\'s *post-hoc* to control). Actual p values can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Genotypes: all animals expressed GCaMP under control of *Ccap*-GAL4 (*Ccap*-GAL4 + UAS-GCaMP). ETHR RNAi: UAS-ETHR RNAi; *Df(ETHR)/+*: hemizygosity for ETHR; MN\>: motoneuron GAL4 (C164; see Materials and methods). In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.004](10.7554/eLife.19686.004)

By contrast, expression of ETHR RNAi in CCAP neurons had a considerable effect on ecdysis behavior ([Figure 2](#fig2){ref-type="fig"}; [@bib31]). In particular, animals monitored free of the puparium expressed a significantly longer and weaker pre-ecdysis than did controls, and none (0/14) ecdysed ([Figure 2B](#fig2){ref-type="fig"}). The defects in pre-ecdysis were rendered more severe in animals hemizygous for *ETHR* ([Figure 2](#fig2){ref-type="fig"}), revealing that the phenotype obtained by knockdown of ETHR using ETHR RNAi is functionally equivalent to that of an *ETHR* hypomorph. Fictive ecdysis behaviors, monitored by expressing GCaMP in motor neurons, showed that the underlying motor program was also severely disrupted in these animals, consistent with the expressed behavior. Indeed, unlike the sequences of calcium responses observed in the motoneurons of control animals ([Figure 1A,B](#fig1){ref-type="fig"}), those of animals expressing ETHR RNAi in CCAP neurons responded to ETH with a smaller and sustained pattern of activity in the posterior region ([Figure 1C](#fig1){ref-type="fig"}), consistent with the longer and weaker pre-ecdysis behavior observed ([Figure 2](#fig2){ref-type="fig"}), and a severe reduction and disorganization in the activity of L and R regions of the CNS, consistent with the observed lack of ecdysis behavior ([Figure 2](#fig2){ref-type="fig"}). These results confirm previous findings ([@bib31], [@bib31]; [@bib36]; [@bib48]) and reveal that CCAP neurons play a critical role in the control of *Drosophila* ecdysis behavior.

Knockdown of ETHR in CCAP neurons also caused significant changes in the calcium response induced by ETH in vitro. In control animals, the two pairs of serial CCAP homologs showed a characteristic response to 600 nM ETH: whereas one set of neurons (called here α neurons, [Figure 3C--E](#fig3){ref-type="fig"}) responded ca. 20 min after ETH challenge with a barrage of GCaMP spikes, the other (called here β neurons, [Figure 3C,D](#fig3){ref-type="fig"}) responded after a similar delay with a sustained increase in fluorescence. Based on the electrophysiological activity recorded in *Manduca* ([@bib21]), we assume that the α neurons correspond to the projection 'Cell 27' neurons, whereas the β neurons correspond to interneurons 'IN704'. Expression of ETHR RNAi in CCAP neurons caused a significant delay in the onset of the response ([Figure 3F,H](#fig3){ref-type="fig"}; [@bib31]), and the period of activity was shorter and included a smaller number of peaks ([Figure 3F,I,J](#fig3){ref-type="fig"}) (In these records, the responses of α and β neurons have been combined as they could not be unambiguously distinguished). This weakening of the response was seen in CCAP neurons in thoracic segment 3 (TN3) as well as in serial homologs in abdominal segments 1--4 (AN1-4) but was not detected in AN8-9, which may not express ETHR ([@bib15]; [@bib31]). Further reduction of ETHR function, accomplished using *ETHR* hemizygosity, did not simply reduce the response further, revealing that indirect as well as direct ETH actions may be involved in determining the response of CCAP neurons to ETH. Indeed, in such animals, the latency to respond was generally more similar to that of the control ([Figure 3G,H](#fig3){ref-type="fig"}), whereas its duration and number of spikes was more similar to those observed when ETHR RNAi was expressed in a wild-type background ([Figure 3I,J](#fig3){ref-type="fig"}). Significantly, however, as illustrated in [Figure 3F,G](#fig3){ref-type="fig"} and quantitated in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}, both manipulations severely reduced the amplitude of the response. Thus, for animals expressing ETHR RNAi it was reduced four-fold for CCAP neurons AN1-4 and AN8-9, and eight-fold in CCAP neurons TN3, AN1-4, and AN8-9 for animals expressing ETHR RNAi in a ETHR hemizygous background. This reduced response may be the basis for the much weaker behavior expressed by these genotypes ([Figures 1C](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). We do not know the cause of the differential effects on CCAP neurons TN3 vs. AN1-4 for these and other manipulations carried out in this study; we assume that they are due to differential ETHR expression and/or synaptic inputs.10.7554/eLife.19686.005Figure 3.Impact on CCAP neuron activation of ETHR knockdown in CCAP neurons.(**A**) Schematic of *Drosophila* nervous system indicating the location of EH, FMRFa, and CCAP neurons. (**B--C**) Snapshots of the pattern of GCaMP signal in CCAP neurons in segments AN1-4, recorded from wild-type animals at 0 min (**B**) and 20 min (**C**) after in vitro challenge with 600 nM ETH. (**D**) Calcium dynamics of AN1 α (top, red trace) and β (lower, blue trace) neurons (cf., 3C) after ETH challenge. (**E--G**) Pattern of GCaMP activity recorded from CCAP neurons AN1-4 following in vitro challenge with 600 nM ETH in wildtype CNSs (**E**), in CNSs expressing ETHR RNAi in CCAP neurons (**F**), and in CNSs of *ETHR* hemizygous animals expressing ETHR RNAi in CCAP neurons (**G**). (**H--J**) Quantitation of time of onset (**H**), duration (**I**), and number of spikes (**J**) for the different genotypes tested. TN3: thoracic ganglion 3; AN: abdominal ganglion. Zero min indicates time of ETH challenge. N = 10 preparations for all genotypes. Data are mean ± SEM. Different letters indicate statistically significant groups (p\<0.05); one-way ANOVA, Tukey\'s *post-hoc* multiple comparison analyses. Actual p values can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Genotypes: all animals expressed GCaMP under control of *Ccap*-GAL4 (*Ccap*-GAL4 + UAS-GCaMP); ETHR RNAi: UAS-ETHR RNAi; *Df(ETHR)/+*: hemizygosity for ETHR. In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.005](10.7554/eLife.19686.005)10.7554/eLife.19686.006Figure 3---figure supplement 1.Amplitude of GCaMP response induced by ETH in CCAP neurons.Quantitation of mean amplitude of GCaMP response to ETH of CCAP neurons in TN3, AN1-4, and AN8-9 for different genotypes and conditions (Note: some of the results shown in this figure relate to data shown in [Figures 4](#fig4){ref-type="fig"}, [5,](#fig5){ref-type="fig"} and [7](#fig7){ref-type="fig"}). (**A**) Results obtained for genotypes that used *Ccap*-GAL4 to drive GCaMP expression. (**B**) Results obtained for genotypes involving *pburs* mutants, for which *Ccap*-LexA was used to drive GCaMP expression (see [Figure 6](#fig6){ref-type="fig"} for further details). N = 6--13 for all conditions. Data are mean ± SEM. One-way ANOVA, followed by Dunnett\'s *post-hoc* analyses to control (**A**) or unpaired two-tailed *t* test to control (**B**); '\*' p\<0.05. Actual p values for all analyses can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. All animals expressed *Ccap*-GAL4+GCaMP (**A**) or *Ccap-*LexA+LexAop-GCaMP (**B**); Df(ETHR)/+ indicates hemizygosity for ETHR; *Eh*\[-\]: *Eh\[-\]/Df(3)Eh; pburs\[-\]: pburs\[-\]/Df(2)pburs*. In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.006](10.7554/eLife.19686.006)

As an alternative approach to studying the response of CCAP neurons to ETH by changing their sensitivity to ETH, we investigated the effects of challenging the CNS with lower doses of ETH. As was observed when ETHR signaling was reduced using RNAi, such manipulations again revealed the presence of non-linear effects. Thus, for instance the lengthening of the latency observed using 300 nM was in general reversed with the lower concentrations (150 nM and 60 nM; [Figure 4E](#fig4){ref-type="fig"}). Interestingly, none of these concentrations significantly affected the duration of the response ([Figure 4F](#fig4){ref-type="fig"}). Nevertheless, the responsiveness of neurons was severely affected, with only around 75%, 50% and 25% of neurons responding when challenged with 300 nM, 150 nM and 60 nM ETH1, respectively (vs. 100% for 600 nM ETH1). Furthermore, the amplitude of the response was significantly decreased for all the lower concentrations used (ten- to forty-fold, depending on segmental location and ETH concentration; [Figure 4B--D](#fig4){ref-type="fig"}-Figure; see also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}).10.7554/eLife.19686.007Figure 4.Calcium responses induced by different concentrations of ETH in CCAP neurons.(**A--D**) Pattern of GCaMP activity recorded from CCAP neurons in AN1-4 from control CNSs challenged in vitro with 600 nM (**A**), 300 nM (**B**), 150 nM (**C**), and 60 nM (**D**) ETH. Zero min indicates time of ETH challenge. (**E--G**) Quantitation of results, shown as described in [Figure 3H--J](#fig3){ref-type="fig"}. N = 10 for all preparations. Data are mean ± SEM. Different letters indicate statistically significant groups (p\<0.05); one-way ANOVA, Tukey\'s *post-hoc* multiple comparison analyses. Actual p values can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. The responsiveness and amplitude of the responses were also affected; see text and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. Individual measurements have been superimposed on the summary histogram when \<8 neurons showed a measurable response. Genotypes: all animals expressed GCaMP under control of *Ccap*-GAL4 (*Ccap*-GAL4 + UAS-GCaMP).**DOI:** [http://dx.doi.org/10.7554/eLife.19686.007](10.7554/eLife.19686.007)

These results show that the response of CCAP neurons to ETH affects the expression of ecdysis behaviors and that this response depends in a nonlinear fashion on the levels of both ligand and receptor. This non-linearity could simply reflect the sigmoidal dose-response curve of GPCRs or may also be caused by inputs to CCAP neurons that are also (direct or indirect) targets of ETH.

Influence of downstream peptides on the pattern of activation of CCAP neurons by ETH: role of eclosion hormone {#s2-3}
--------------------------------------------------------------------------------------------------------------

Eclosion hormone (EH) is a key neuropeptide in the control of ecdysis ([@bib17]; [@bib21]; [@bib35]). It is involved in potentiating and accelerating the release of ETH that causes the sudden onset of ecdysis behaviors ([@bib17]; [@bib34]); in addition, it plays a critical role within the CNS for the expression of ecdysis behaviors. In *Drosophila* larvae, for instance, mutants lacking EH do not express pre-ecdysis, transitioning directly into a prolonged ecdysis-like phase, which is, nevertheless, generally ineffective in causing the shedding of the old cuticle ([@bib35]). *Eh* mutant animals also expressed specific behavioral defects at pupal ecdysis, which, interestingly, differed from those expressed in the larva. Thus, intact *Eh* hemizygous mutants expressed much longer pupal pre-ecdysis ([Figure 5A](#fig5){ref-type="fig"}) and ecdysis behavior was also longer, with most animals (4/10) failing to express the behavior. Similar defects were observed in puparium-free preparations ([Figure 5B](#fig5){ref-type="fig"}), although in this case none (0/10) expressed the ecdysial phase of the behavior. These defects were all qualitatively rescued using a transgene containing the *Eh* gene, indicating that they were mostly due to the lack of EH ([Figure 5A,B](#fig5){ref-type="fig"}, for intact and puparium-free preparations, respectively).10.7554/eLife.19686.008Figure 5.Absence of EH abolishes ecdysis and alters the response of CCAP neurons to ETH.(**A,B**) Duration of pre-ecdysis (left; open bars) and ecdysis (right; filled bars) behavior of animals hemizygous for *Eh* in intact (**A**) and puparium-free preparations (**B**), shown as described in [Figure 2](#fig2){ref-type="fig"}. Behavioral defects in (**A, B**) were qualitatively rescued by transgene containing *Eh* gene, indicating that they are caused by lack of EH neuropeptide. (**C,D**) Pattern of GCaMP activity in CCAP neurons AN1-4 induced by ETH in CNS from control animals (**C**) and from animals hemizygous mutant for *Eh* (**D**). Zero min indicates time of ETH challenge. (**E**) Summary of results obtained for latency (left) and duration (right) of response. (**F**) Recording from motoneurons from CNS of controls (left; cf. [Figure 1B](#fig1){ref-type="fig"}) and animals hemizygous for *Eh* (right); traces color-coded as described in [Figure 1](#fig1){ref-type="fig"}. Zero min indicates time of ETH challenge. N = 6--10 for all genotypes. Data in (**A**, **B**, and **E**) are mean ± SEM. One-way ANOVA, Dunnett\'s *post-hoc* to control; (\*: p\<0.05; \*\*: p\<0.01); actual p values can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. The amplitude of the responses was also affected; see text and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. In (**E**), individual measurements have been superimposed on the summary histogram when \< 8 neurons showed a measurable response. Genotypes: in (**A--D**) all animals expressed GCaMP under control of *Ccap*-GAL4; in (**F**), they expressed GCaMP under control of MN-GAL4 (C164-GAL4). *Eh*\[-\]: *Eh\[-\]/Df(3)Eh; Eh*\[-\]+P{*Eh*}: *Eh\[-\]/Df(3)Eh*; P{*Eh*}; see Materials and methods for exact genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.008](10.7554/eLife.19686.008)

*Drosophila* EH neurons are direct targets of ETH ([@bib15]; [@bib31]) and respond to ETH with a shorter latency than do CCAP neurons ([@bib31]); in addition, the response of larval CCAP neurons to ETH is severely weakened in the absence of EH ([@bib35]). These results suggest that EH neurons are an ETH target that is upstream of CCAP neurons. In order to explore the role of EH in determining the features of the response of CCAP neurons to ETH at pupal ecdysis, we examined the GCaMP signal of CCAP neurons to ETH in animals hemizygous mutant for *Eh*. As shown in [Figure 5D](#fig5){ref-type="fig"}, the temporal organization of the response was dramatically disorganized in these animals, with a significant loss in the regular pattern of GCaMP spikes that is typical of the control ([Figure 5C](#fig5){ref-type="fig"}). This effect was partially reflected in the quantitation of the response, where the lack of EH caused significant increases in the latency to respond ([Figure 5E](#fig5){ref-type="fig"}) and a two-fold decrease in the amplitude of the response in CCAP neurons AN1-4 and AN8,9 ([Figure 5D](#fig5){ref-type="fig"}; see also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}), although the severely disrupted response (cf., [Figure 5D](#fig5){ref-type="fig"}) precludes a quantitative comparison. These results show that, as occurs in the larva, the response of CCAP neurons to ETH depends critically on the action of EH.

Animals hemizygous mutant for *Eh* also expressed a severely weakened and disrupted pattern of motoneuron activity in response to ETH ([Figure 5F](#fig5){ref-type="fig"}). This aberrant response is consistent with the failure of ecdysis behavior observed in this genotype ([Figure 5A,B](#fig5){ref-type="fig"}), although in the intact animal the absence of EH would likely also prevent ETH release ([@bib35]), which may also contribute to the failure of ecdysis,

Influence of downstream peptides on the pattern of activation of ETH targets: role of PBURS {#s2-4}
-------------------------------------------------------------------------------------------

Bursicon, the so-called tanning hormone, has traditionally been implicated in post-ecdysial events following adult emergence ([@bib27]). However, genetic analyses have shown that *pburs*, which encodes one of the subunits of the heterodimeric bursicon hormone, also plays a role in the control of ecdysial behaviors ([@bib36]). Bursicon is of particular interest in the context of this work because it is expressed by a subset of the CCAP neurons themselves and could therefore play a (direct or indirect) autocrine role in determining the response of these neurons to ETH. Consistent with the findings of [@bib36], the lack of PBURS (and thus of the heteromeric bursicon) in intact puparia caused a lengthening of ecdysis, with only 5/8 animals executing the behavior ([Figure 6A](#fig6){ref-type="fig"}). Puparium-free preparations lacking PBURS, by contrast, expressed a significantly shorter ecdysis motor program ([Figure 6B](#fig6){ref-type="fig"}); a similar defect was obtained expressing *pburs* RNAi in CCAP neurons ([Figure 6B](#fig6){ref-type="fig"}). Importantly, the defects expressed by hemizygous mutant animals in both types of preparations were rescued by a transgene containing the *pburs* gene ([Figure 6A,B](#fig6){ref-type="fig"}) indicating that they are due to the lack of *pburs* function. The apparently opposite phenotypes expressed by these two types of preparations are likely due to the different criteria that are used to define the ecdysial phases in intact vs. puparium-free animals. At the level of the response of CCAP neurons, the lack of PBURS caused, on average, a two-fold decrease in the amplitude of the response to ETH of CCAP neurons AN1-4 ([Figure 7B](#fig7){ref-type="fig"}; see also [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). (These and other experiments involving mutations in *pburs* had to be done using the LexA/LexAop binary expression system due to interference from GAL4; see legend to [Figure 6](#fig6){ref-type="fig"} for further details.) It also accelerated the time of onset and shortened the response for some of the CCAP neurons ([Figure 7C,D](#fig7){ref-type="fig"}). No effects on the timing or amplitude of the response were detected in CCAP neurons AN8-9, suggesting that they may not express the bursicon receptor. In summary, the absence of *pburs* function caused quantitative changes to the response of CCAP neurons to ETH, revealing that a neurohormone made by the CCAP neurons themselves participates in determining their response to the ETH trigger.10.7554/eLife.19686.009Figure 6.Ecdysial behaviors of *pburs* mutant animals.(**A,B**) Duration of pre-ecdysis (left; open bars) and ecdysis (right; filled bars) behavior of animals hemizygous for *pburs* in intact (**A**) and in puparium-free preparations (**B**), shown as described in [Figure 2](#fig2){ref-type="fig"}. Data are mean ± SEM; one-way ANOVA, Dunnett\'s *post-hoc* to control. Actual p values can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Lack of *pburs* function did not significantly alter the duration of the pre-edysis phase (unless CCAP neurons also expressed GAL4, see below), whereas it lengthened (intact preparations) or shortened (puparium free preparations) the duration of ecdysis; a similar result was obtained when *pburs* function was knocked down using RNAi. In (**A**), note that expression of GAL4 in CCAP neurons accentuated the defects expressed by *pburs* hemizygotes; these defects could not be rescued by *pburs*-containing transgene and were therefore not caused only by the lack of *pburs* function. For this reason, GCaMP responses to ETH of *pburs* mutants were assessed using *Ccap*-LexA driver (cf., [Figure 7](#fig7){ref-type="fig"}). Genotypes: Control (GAL4): CCAP-GAL4+UAS-GCaMP; Control (LexA): CCAP-LexA+LexAop-GCaMP. All genotypes including \'(GAL4)\' or (\'LexA\') contained CCAP-GAL4+UAS-GCaMP or CCAP-LexA+LexAop-GCaMP, respectively. *pburs\[-\]: pburs\[-\]/Df(2)pburs; pburs*\[-\]+P{*pburs*}: *pburs\[-\]/Df(2)pburs*; P{*pburs*}; see Materials and methods for exact genotypes. In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.009](10.7554/eLife.19686.009)10.7554/eLife.19686.010Figure 7.Absence of PBURS affects response of CCAP neurons to ETH.(**A,B**) Pattern of GCaMP activity in CCAP neurons AN1-4 induced by ETH in CNS from control animals (**A**) and in CNS of animals hemizygous mutant for *pburs* (**B**). Zero min indicates time of ETH challenge. (**C,D**) Summary of results obtained for latency (**C**) and duration (**D**) of response, summarized as described in [Figure 5](#fig5){ref-type="fig"}. N = 7--10 for all genotypes and preparations. Data in (**C,D**) are mean ± SEM. Significant differences (p\<0.05) compared to control are indicated by \'\*\'; *t* test (unpaired, two-tailed). Actual p values can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. The amplitude of the responses was also affected; see text and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}. Genotypes: Control: CCAP-LexA+LexAop-GCaMP. *pburs\[-\]: pburs\[-\]/Df(2)pburs* + CCAP-LexA+LexAop-GCaMP; see Materials and methods for exact genotypes.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.010](10.7554/eLife.19686.010)

Inhibitory influences in the activation of ecdysis sequence {#s2-5}
-----------------------------------------------------------

A striking feature of the responses triggered by ETH on its peptidergic targets is that, despite all being direct targets of this triggering hormone, the various subsets of peptidergic neurons are not activated simultaneously following an in vitro ETH challenge. Thus, although EH ([@bib31]) and Kinin ([@bib15]; [@bib31]) neurons respond within ca. 10 min of an ETH challenge, CCAP neurons do not respond until around ca. 20 min after ETH stimulation, with different subsets showing different and characteristic latencies ([Figure 8C,F](#fig8){ref-type="fig"}; [@bib31]). The delay in the execution of the ecdysial phase of ecdysis behavior, which correlates with the time of activation of CCAP neurons, has been hypothesized to occur through inhibitory influences originating from the brain and/or subesophageal ganglion ([@bib4]; [@bib17]); [@bib17]; [@bib20]; [@bib16]). Nevertheless, the exact origin and nature of this inhibition is currently unknown. In order to investigate the role of inhibition in the response of CCAP neurons to ETH, we first examined their time course of activation in the presence of the GABA~A~ receptor (GABA-RA) blocker, picrotoxin (100 µM; [@bib53]). As shown in [Figure 8D,F](#fig8){ref-type="fig"}, pharmacological inhibition of GABA-RA caused a significant reduction in the latency to respond; this effect was most dramatic in neurons from segments AN1-4, where the time to onset was reduced by almost 50% (from around 20 to 10 min). Other changes were also apparent in these preparations. Most noteworthy was the more sustained nature of the response ([Figure 8D](#fig8){ref-type="fig"}), which suggests that the pronounced spikes that are normally seen (e.g., [Figure 8C](#fig8){ref-type="fig"}) are partly accomplished through inhibitory processes mediated by GABA. Similar results were obtained using the GABA-RA inhibitor, gabazine (100 µM; [@bib28]; data not shown).10.7554/eLife.19686.011Figure 8.GABA inhibition controls latency to ecdysis and of CCAP response to ETH.(**A,B**) Duration of pre-ecdysis (left; open bars) and ecdysis (right; filled bars) behavior in intact (**A**) and in puparium-free (**B**) preparations expressing GABA-RA RNAi in CCAP neurons; results are summarized as shown in [Figure 2](#fig2){ref-type="fig"}. Animals also expressed GCaMP under control of *Ccap*-GAL4. (**C--E**) Pattern of GCaMP activity in CCAP neurons AN1-4 induced by ETH in CNSs from control animals (**C**), in CNSs from control animals recorded in the presence of GABA-RA antagonist picrotoxin (100 µM) (**E**), and in CNSs expressing GABA-RA RNAi in CCAP neurons (**E**). (**F--H**) Quantitation of results, shown as described in [Figure 3H--J](#fig3){ref-type="fig"}. Zero min indicates time of ETH challenge. N = 9--13 for all genotypes and preparations. Data in (**A**,**B**, **F--H**) are mean ± SEM. For panels **A** and **B**, data for experimental groups were compared to those of control (one-way ANOVA, Dunnett\'s *post-hoc* to control), and summarized as described in [Figure 2](#fig2){ref-type="fig"}. For panels **F--H**, different letters indicate statistically significant groups (p\<0.05); one-way ANOVA, Tukey\'s *post-hoc* multiple comparison analyses. Actual p values for all analyses can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. All animals also expressed GCaMP under control of *Ccap*-GAL4 (*Ccap*-GAL4 + UAS-GCaMP). In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.011](10.7554/eLife.19686.011)

In order to determine the contribution of inhibitory processes acting directly on CCAP neurons, we expressed GABA-RA RNAi in these ETH targets. As illustrated in [Figure 8E](#fig8){ref-type="fig"} and quantitated in [Figure 8F](#fig8){ref-type="fig"}, this manipulation caused a significant shortening of the response latency, which, furthermore, was similar to that observed following picrotoxin inhibition ([Figure 8D,F](#fig8){ref-type="fig"}), but without significantly affecting the other features of the response (duration and number of spikes, [Figure 8G and H](#fig8){ref-type="fig"}, respectively). Importantly, the corresponding animals expressed a significantly shorter pre-ecdysis, thereby reducing the latency to ecdysis ([Figure 8A,B](#fig8){ref-type="fig"}). These results show that around 50% of the latency of the response of CCAP neurons to ETH is caused by GABA inhibition acting directly on these neurons. They also again show the importance of CCAP neurons in the control of ecdysis since reducing the latency of the onset of the GCaMP response was accompanied by a comparable shortening in the time of onset of ecdysis.

Direct measurement of GABA-mediated inhibition {#s2-6}
----------------------------------------------

In order to more directly visualize the inhibitory processes acting on CCAP neurons, we carried out optical voltage recordings of these neurons using the genetically encoded voltage sensor, ArcLight ([@bib8]). As shown in [Figure 9B](#fig9){ref-type="fig"}, two different responses could be recorded in preparations where an α + β pair of CCAP neurons was in focus (neurons from neuromeres A8 and A9 could not be visualized so are omitted from these analyses): although both neurons showed an initial plateau (top red and blue records in [Figure 9B](#fig9){ref-type="fig"}) followed by a depolarization at around 20 min (black arrowheads in [Figure 9B](#fig9){ref-type="fig"}), one of them (top red record in [Figure 9B](#fig9){ref-type="fig"}) then showed a series of spikes, whereas the other (top blue record in [Figure 9B](#fig9){ref-type="fig"}) showed a more sustained response. We assume that the neuron expressing the spikes corresponds to the α neuron ([Figure 3D](#fig3){ref-type="fig"}), whereas the other corresponds to the β member of the pair. Most importantly, the main effect of challenging the preparations with ETH in the presence of picrotoxin was a shortening of the latency to depolarize, without significantly affecting the total duration of the entire response ([Figure 9C](#fig9){ref-type="fig"}). Finally, a quantitative analysis of the latency and duration of the voltage vs. GCaMP response ([Figure 9D](#fig9){ref-type="fig"}) reveals that both responses show an overall very similar timecourse. These results suggest that GABA inhibition delays the depolarization of CCAP neurons caused by ETH. This inhibition would then be lifted at around 20 min, causing the depolarization and firing of CCAP neurons, which results in the calcium spikes recorded using the GCaMP sensor ([Figure 8C](#fig8){ref-type="fig"}) and the activation of the ecdysis motor program.10.7554/eLife.19686.012Figure 9.GABA delays depolarization of CCAP neurons induced by ETH.(**A**) ArcLight fluorescence in CCAP neurons α and β from ganglion AN1-2. (**B**) ArcLight signal recorded from α (red trace) and β (blue trace) neurons following ETH stimulation in control CNS (+ETH; top traces) and in the presence of picrotoxin (+ETH+Px, lower traces). Zero min indicates time of ETH challenge. Inverted triangles indicate start and end of depolarization; \'Duration\' corresponds to the time between these two events. (**C**) Quantitation of results showing time of onset of depolarization (top) and duration of depolarization (bottom) in CCAP neurons from TN3 and AN1-4 (neurons in AN8 and AN9 could not be visualized). (**D**) Comparison between timecourse of GCaMP and ArcLight signal. Data in (**C,D**) are mean ± SEM. N = 10--13 for all genotypes. In (**C**), statistically significant differences (p\<0.05) relative to control are indicated with \'\*\'; *t* test (unpaired, two-tailed). In (**D**), statistically significant differences (p\<0.05) are indicated by different letters; one-way ANOVA, Tukey\'s *post-hoc* multiple comparison analyses. Actual p values for all analyses can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Individual measurements have been superimposed on the summary histogram when \<8 neurons showed a measurable response. Genotype of animals expressing ArcLight sensor: CCAP\>Arclight; of those expressing GCaMP: CCAP\>GCaMP.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.012](10.7554/eLife.19686.012)

Discussion {#s3}
==========

Ecdysis behavior consists of behavioral routines and physiological events that are expressed in a specific sequence. At the neural level, the sequential nature of ecdysis is based on the sequential activation of different ETH targets. Here, we have identified some of the elements involved in determining the time course of activation of CCAP neurons. The CCAP neurons express ETHR, and by targeting ETHR RNAi to these neurons we showed that the timecourse and intensity of their response to ETH is sensitive to the dosage of ETHR. The associated lengthening of pre-ecdysis and failures in ecdysis underscore the well-established role for these neurons as key regulators of ecdysis ([@bib31], [@bib31]; [@bib36]; [@bib48]). In addition to ETH, however, we show that several elements downstream of this triggering hormone including EH, PBURS, and GABA play a key role in determining the response of CCAP neurons (whether GABA neurons mediating this inhibition are direct or indirect targets of ETH is currently unknown). Thus, we found that the response of CCAP neurons is qualitatively changed in the absence of EH, causing a decrease in the amplitude and dramatically altering the temporal features of the response, with a concomitant failure to ecdyse. Interestingly, we show that PBURS, which is produced by a subset of CCAP neurons, is also involved in patterning the response of these neurons to ETH, revealing a (direct or indirect) autocrine regulation of CCAP activation. Finally, we show that GABA inhibition mediates at least part of the delay between exposure to ETH and CCAP neuron activation and may also sculpt the shape of the resulting pattern of activation. Our findings are summarized in the model shown in [Figure 10](#fig10){ref-type="fig"}; the model details the contributions to the activation of CCAP neurons from ETH, peptides produced by targets of ETH including the CCAP neurons themselves, as well as inhibitory effects mediated by GABA, and define the times when these influences participate during the expression of the different phases of ecdysis. In addition to these actions, there are several features of the response to ETH whose origins await elucidation. For instance, decreasing ETH effectiveness using RNAi or different concentrations of ETH revealed the existence of non-linear processes whose basis is currently unknown. They could simply reflect the non-linear activation of GPCRs and/or may occur because the various targets that are activated or inhibited by ETH may respond differentially and non-linearly to different concentrations of this neuropeptide, as occurs in other cases of neuromodulation ([@bib7]; [@bib43]). Similarly, there remains a 10-min delay in the onset of the response of CCAP neurons that is not mediated by GABA inhibition. Dissecting the contributions of different modulators and their targets to the response of this neuronal ensemble will undoubtedly be aided by the availability of recently developed genetic tools ([@bib15]; [@bib42]) that can be used for the precise manipulation of receptor spatial expression. Finally, we still do not know how the activation of the various peptidergic targets of ETH causes the production of the ecdysial motor programs (cf., [Figure 1A,B](#fig1){ref-type="fig"}). Preliminary evidence indicates that CCAP may play an important role in directly activating these motor programs because the timing of GCaMP activity in motoneurons follows closely the pattern of GCaMP activity of CCAP neurons (Mena and Ewer, unpublished).10.7554/eLife.19686.013Figure 10.Model for endocrine control of ecdysial behaviors.(**A**) ETH released from peripheral endocrine cells acts directly on EH and CCAP neurons, and directly or indirectly on GABA neurons. Release of ETH is further potentiated by ETH-induced EH release (reciprocal arrows). Direct GABA inhibition of CCAP neurons prevents onset of response. (**B**) EH and/or ETH turn on the preparatory phase of ecdysis; waning of GABA inhibition, and EH and autocrine PBURS action (presumably mediated by BURS+PBURS bursicon heterodimer) on CCAP neurons activates CCAP neurons. (**C**) Activation of CCAP neurons causes expression of ecdysis proper and silencing of pre-ecdysis phase. Except for reciprocal relationship between EH and ETH, and ETH actions on CCAP neurons, none of the actions indicated are known to be direct. Arrows indicate stimulation; cross bars indicate inhibition.**DOI:** [http://dx.doi.org/10.7554/eLife.19686.013](10.7554/eLife.19686.013)

In many motor systems, repetitive motor outputs are produced by central pattern generators (CPG's) whose exact pattern of activity is then modulated by biogenic amines and neuropeptides ([@bib7]; [@bib43]; [@bib47]). In the case of the ecdysis motor program, intrinsic modulatory actions ([@bib29]) appear to play a defining role in the expression of the neural response elicited by ETH and of its accompanying motor output. Thus, for example, the lack of EH destroys the repetitive pattern of firing of CCAP neurons induced by ETH ([Figure 5D](#fig5){ref-type="fig"}) as well as that of the resulting motor output ([Figure 5A,B and F](#fig5){ref-type="fig"}). What might the advantage be of not hardwiring the neural bases of such a vital behavior as ecdysis? One clue may lie in the fact that, despite the diversity in ecdysial behaviors expressed by different arthropods during different molts, the neuropeptides that drive ecdysis as well as their receptors are extremely well conserved, and clear homologs can be identified even in chelicerates ([@bib12]; [@bib24]; [@bib60]), which diverged from the insects ca. 600 million years ago ([@bib50], [@bib50]). One way for such a conserved signaling pathway to produce different behavioral outputs would be to change the pattern of receptor expression. Consistent with this hypothesis, the exact function of particular ecdysial neuropeptides can differ in different insect groups and stages ([@bib17]). For instance, whereas *Drosophila* lacking CCAP express normal ecdysis behaviors ([@bib36]), RNAi inhibition of CCAP causes ecdysial failures in *Tribolium* ([@bib1]). Likewise, bursicon is involved in postecdysial maturation following the emergence of the adult fly ([@bib27]), yet is involved in the control of the earlier ecdysial phase at pupation ([@bib36]). Finally, it is especially interesting to identify an inhibitory input to CCAP neurons mediated by GABA, as it could provide a route through which sensory input could modulate the time of onset of the ecdysial phase. Such an input appears to be absent in *Drosophila* larval and pupal ecdysis but plays an important role in orthopteran ecdysis ([@bib10]; [@bib17]) as well as in dipteran ([@bib4]) and lepidopteran adult emergence ([@bib17]). It will be very interesting to determine the extent to which differences in neuropeptide receptor expression underlie the diversity of ecdysial behaviors expressed by insects with different body plans. In other systems, the different responses elicited by well-conserved neuropeptides may also be accomplished through changes in receptor expression. Such appears to be the case for oxytocin in voles, where differences in pair bonding in monogamous vs. gregarious species are at least in part due to differences in receptor distribution ([@bib67]).

Neuropeptides can be released at synapses, along axons, and even from dendrites, from where they can influence distant targets with a timecourse that can span from seconds to hours ([@bib38]; [@bib59]). Despite this mode of delivery, with low spatial and temporal specificity, their actions are typically very specific and can lead to the expression of tightly regulated responses. In the case of ecdysis behavior, for example, EH and CCAP are both broadly released into the ventral CNS, yet the timing of pre-ecdysis and ecdysis is normally extremely precise ([Figure 2](#fig2){ref-type="fig"}). Similarly, in the case of the mammalian circadian system, robust and precise circadian rhythmicity of pacemaker activity in the suprachiasmatic nucleus (SCN) and of the behavioral output depends on Vasoactive Intestinal Peptide (VIP), which is released in a broad paracrine manner in the SCN ([@bib25]). A similar situation may occur in the *Drosophila* circadian system, where the neuropeptide, Pigment Dispersing Factor (PDF), is critical for the coupling of the different circadian oscillators ([@bib41]; [@bib54]; [@bib65]; [@bib66]). Overall, these examples show that neuropeptides play a critical role in determining the precise output of a neural network and of the behavior it controls. In the case of ETH, the precision of the timing and phasing of the different ecdysial phases depends on its combinatorial actions with other neuropeptides including EH and CCAP, and which are likely to be highly non-linear ([@bib7]; [@bib43]). A similar situation applies for other neuropeptide controlled behaviors such as hunger, where neurons in the hypothalamic arcuate nucleus that express Agouti-related protein (Agrp) regulate feeding by integrating inputs mediated by circulating hormones (ghrelin and letpin), transmitters (glutamate, and GABA) and other peptidergic neurons (POMC neurons) ([@bib2]; [@bib23]; [@bib55]). These inputs provide a readout of the animal's physiological state and are then translated into a non-linear switch-like behavior, consistent with the switch-like features of hunger states ([@bib64]). For most systems, however, we lack information on the detailed actions exerted by each neuropeptide within a network. The inner working of the peptidergic network that controls ecdysis provides a tractable system for understanding how neuropeptides trigger and modulate complex patterns of neuronal activity and behaviors.

Materials and methods {#s4}
=====================

Fly strains and genetics {#s4-1}
------------------------

Flies stocks were maintained at room temperature (22--25°C) on standard agar/cornmeal/yeast media. Unless indicated otherwise, all strains were obtained from the *Drosophila* Bloomington stock center (Bloomington, Indiana, USA). The following GAL4 drivers were used; expression and reference are indicated in parenthesis: *Ccap-GAL4* (CCAP neurons; [@bib48]); *Eh-GAL4* (EH neurons; [@bib45]); *FMRFa-GAL4* (subset of FMRFa neurons; [@bib56]); *C164-GAL4* (motoneurons; [@bib58]). RNAi lines were obtained from Vienna *Drosophila* RNAi Center (VDRC; Vienna, Austria) or the National Institute of Genetics (NIG; Shizuoka, Japan): UAS*-ETHR* RNAi (VDRC \#42717); UAS-*pburs* RNAi (NIG 15284 R-1). In all experiments using RNAi, its effectiveness was boosted by including a UAS-*dcr2* transgene. The null allele of *pburs* is described in [@bib36]; the null allele of *Eh* and an *Eh* rescue transgene are described in [@bib35]. UAS-GCaMP 3.2 was kindly provided by J. Simpson (HHMI, Janelia farms, USA).

Homozygous null animals were always heterozygous for a null allele in combination with a genetic deletion that included the relevant gene (*Df(2)Exel6036* for *pburs*; [@bib36] and *Df(3)Eh\[-\]* for *Eh*; [@bib35]). Stocks with homozygous lethal mutations were maintained heterozygous with *actin-GFP* expressing balancer chromosomes. All UAS-transgene bearing flies were crossed with wild-type animals to create heterozygous controls.

### *Ccap*-LexA {#s4-1-1}

The promoter region from −512 to +44 from the Ccap transcription start was obtained by PCR from a Y17 vector containing DNA immediately 5' of the Ccap transcription start ([@bib48]); kindly provided by Benjamin White) using the forward Gateway primer 5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTAGAGAGTCGCCTCGAAATTGCCTC and a reverse primer with (5´-GGGGAC AACTTTTGTATACAAAGTTGTGATCCACTTAGCAACCGACGCGC-3´) or without a minimal hsp-promotor sequence (5´- GGGGACCACTTTGTACAAGAAAGCTGGGTGATCCACTTAGCAACCGACGCGC-3´). The PCR products were cloned into the Gateway pCasper-W-LexA::GAD vector ([@bib16]) and their sequence confirmed. The recombinant Ccap-promoter-LexA::GAD fusion construct (Ccap-LexA) was introduced into the germline of w\[1118\] flies using standard methods by BestGene (Chino Hills, CA). Several independent transformant lines were obtained.

### *pburs* rescue transgene {#s4-1-2}

Flies bearing a *pburs* rescue transgene were created by transforming flies carrying a suitable ΦC31 'landing pad' on chromosome III with PacMan clone CH322153L1 ([@bib61]). This clone is approximately 19.8 Kb in length and is centered on the *pburs* gene. Transformation was carried by Best Gene (Chino Hills, California, USA).

Behavioral analyses {#s4-2}
-------------------

### Intact puparium preparation {#s4-2-1}

Animals that had recently pupariated were examined and those containing a bubble in the mid-region of the puparium (late stage p4(i); [@bib3]) were selected. Preliminary characterization of pupal ecdysis behavior was carried out using intact pupae, as described in [@bib36]. Briefly, the pupae were selected and placed on their side on a microscope slide, and filmed at room temperature (20--22°C) under dim transmitted light using a Leica DMLB microscope (10 X magnification). One experimental and one control animal was filmed simultaneously.

### Puparium-free preparation {#s4-2-2}

Detailed characterization of ecdysis behavior was done using puparium-free preparations, as described in [@bib31]. Briefly, immediately after the first signs of onset of ecdysial behaviors the pupa was surgically removed from the puparium in a drop of PBS (137 mM NaCl, 2,7 mM KCl, 10 mM Na~2~HPO~4~ and 2 mM KH~2~PO~4~, pH 7.3), and placed in a recording chamber filled with halocarbon oil (Sigma-Aldrich Chemical Co., MO) in order to prevent desiccation. The animals were filmed at room temperature (20--22°C) under dim transmitted light using a Leica DMLB microscope (20 X magnification).

Imaging of Ca^2+^ and voltage dynamics {#s4-3}
--------------------------------------

Imaging of Ca^2+^ dynamics was carried out essentially as described in [@bib31]. Briefly, animals containing a bubble in the mid-region of the puparium (late stage p4(i); [@bib3]) were selected. They were then further staged to be within 4 hr before onset of pupal ecdysis. The animals were then dissected under cold PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~ and 2 mM KH~2~PO~4~, pH 7,3), placed on the surface of 200 µl, 1.5% low melting temperature agarose solution (Sigma type VII-A; Sigma-Aldrich Chemical Co., MO), which was then left to harden for 30 min in a humidified chamber kept at 10--15°C. Preparations were then covered with Schneider´s Insect Medium (Sigma-Aldrich Chemical Co., MO) and imaged under an Olympus DSU Spinning Disc microscope (Olympus Corporation, Shinjuku-ku, Tokyo, Japan) using a 20 X W NA 0.50 or 40 X W NA 0.80 immersion lens. Fluorescent images were acquired using an ORCA IR2 Hamamatsu camera (Hamamatsu Photonics, Higashi-ku, Hamamatsu City, Japan) using the Cell^\^^R Olympus Imaging Software (Olympus Soft Imaging Solutions, Munich, Germany). Preparations were first imaged for 5 min (exposures taken every 5 s) and those showing spontaneous activity (ca. 5% of the preparations) were discarded. They were then stimulated with synthetic ETH1 (Bachem Co., USA; referred to here simply as ETH) and GFP fluorescence captured every 5 s for 30, 60, or 90 min for the Ca^2+^ sensor, GCaMP, and every 2 s for 60 min for the voltage sensor, ArcLight. When used, antagonists for GABA receptor A, Picrotoxin (Sigma-Aldrich Chemical Co., MO) or Gabazine (SR95531; Tocris Bioscience, Bristol, UK), were added 10 min prior to ETH1 challenge.

Analysis of GCaMP and voltage intensity timecourses {#s4-4}
---------------------------------------------------

Recordings were analyzed using Cell^\^^R Olympus Imaging Software (Version 2.6) and fluorescence intensity calculated as ∆F/F. The data were further processed with Excel (Microsoft, WA); statistical analyses were carried out using Prism 6.0 (Graphpad Software Inc, CA). In general, only 50--75% of CCAP neurons were in focus in a given preparation and could therefore be quantitated. However, since for most genotypes and manipulations 90--100% of neurons showed a measurable response, each preparation yielded at least one independent measurement per segment. Exceptions to this were neurons in segment T3, where only one pair of neurons showed a measurable signal; and for some genotypes and manipulations, where many neurons failed to respond (e.g. preparations challenged with 60 nM ETH1; cf. [Figure 4](#fig4){ref-type="fig"}). In cases where \<8 measurements were obtained, individual data points have been superimposed on the relevant summary histograms ([Figures 4](#fig4){ref-type="fig"}, [5,](#fig5){ref-type="fig"} and [9](#fig9){ref-type="fig"}).
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Thank you for submitting your article \"Stereotyped responses of *Drosophila* peptidergic neuronal ensemble depend on downstream neuromodulators\" for consideration by *eLife*. Your article has been favorably evaluated by Eve Marder (Senior Editor) and three reviewers, one of whom, Ronald L Calabrese (Reviewer \#1), is a member of our Board of Reviewing Editors. The following individuals involved in review of your submission have agreed to reveal their identity: Orie T Shafer (Reviewer \#2) and Hans-Willi Honegger (Reviewer \#3).
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Summary:

This study combines the use of genetically encoded calcium- and voltage-sensitive probes, targeted RNAi expression, mutants null for particular neuropeptides downstream of ETH, and pharmacology, to understand how pupal ecdysis is orchestrated in *Drosophila*. Focusing on a subset of neurons that produce CCAP (Crustacean cardioactive peptide), which known play a key role in the control of ecdysis, they show that the response of CCAP neurons to ETH and the ensuing ecdysis behaviors depend on direct actions mediated by ETH as well as on the actions of neuropeptides downstream of ETH together with inhibition mediated by GABA. Removal of a downstream neuropeptide, EH, can eliminate the rhythmic pattern of neuronal activity induced by ETH. These results indicate that neuropeptides are critical for the expression of the fundamental features, including timing of the underlying neuronal program for pupal ecdysis. The work has broad implication for how neuropeptides can orchestrate complex behaviors and imply that they build flexibility into neuronal networks that can be exploited developmentally and evolutionarily.

Essential revisions:

There are a few concerns about controls (detailed in reviewer \#2 comments) and also some concerns about the complexity of the figures, particularly [Figure 4](#fig4){ref-type="fig"}. The manuscript focuses on two major questions: 1) Which mechanisms are responsible for producing the sequential activation of neuronal targets in response to a common ETH stimulus (latency responses), and 2) How does the amplitude of the CCAP response (Ca+ fluorescence) relate to the ecdysis motor pattern. These questions may help in the reorganization of the Figures. The authors may break up the results of their experimental approach in the figures more clearly with respect to answering these questions. The major concerns of reviewers \#2 and \#3 are listed below to guide in your revision.

Minor points:

See minor revisions suggested by each reviewer (below).

*Reviewer \#1:*

Explain the statistical differences more fully in the text. Give exact p values.

*Reviewer \#2:*

There are two concerns that, if addressed, would improve this important study.

First, some critical experimental details are not adequately described in the manuscript. For example, the genotypes of the flies used in imaging experiments on RNAi manipulated brains should be clearly indicated either in the Results section or figure legend for every experiment. For example, it isn\'t clear from the description of the imaging experiments in [Figure 2](#fig2){ref-type="fig"} how GCaMP and the ETH-R RNAi constructs were independently driven in motor neurons and CCAP expressing neurons, respectively. Was the CCAP-LexA used to drive UAS-RNAi? If so, there does not seem to be a LexAop-ETH-RNAi element described. Or was a LexA used for motor neurons (in which case the driver and the LexAop-GCaMP should be described)? With the genotypes unclear, it is difficult to access how well controlled these experiments are. For example, how well have the authors controlled for the possibility of leaky RNAi expression in the imaging experiments? Some evidence that the genetic driver is required for the RNAi effects would strengthen these experiments. The authors should ensure that every fly line used in the study is described in the Methods section.

Second, a reorganization of the figures would make this excellent manuscript more easily read. As organized, there are several highly related experiments that are spread over two or even three figures in the manuscript. The need to move between multiple figures to compare behavioral and physiological data for similar experimental manipulations makes the manuscript difficult to follow at times. For example, [Figure 4](#fig4){ref-type="fig"} does a nice job summarizing a great deal of data, but as presented it is a bit challenging to navigate. I would consider breaking these data up among the other figures. The reader would be better served if the ETH-R knockdown data in [Figure 4](#fig4){ref-type="fig"} were included in the current [Figure 3](#fig3){ref-type="fig"} and if the ETH dose response data were combined with the current [Figure 5](#fig5){ref-type="fig"}. Likewise, the authors might break up the comprehensive behavioral data shown in [Figure 1](#fig1){ref-type="fig"}, placing the various genetic manipulations alongside the imaging done on the same manipulations. This would allow the reader to move more easily from one figure to the next while reading the Results section.

*Reviewer \#3:*

There are a few concerns that should be addressed:

1\) The figures indicate that the response of CCAP neurons in T3 to the diverse experimental manipulations differ from those in the abdominal neuromers 1-4 (AN1-4), see [Figure 3](#fig3){ref-type="fig"}, \# of spikes; [Figure 4](#fig4){ref-type="fig"}, amplitude of GCaMP response; [Figure 5](#fig5){ref-type="fig"} and [8](#fig8){ref-type="fig"}, \# of spikes; [Figure 9](#fig9){ref-type="fig"}, duration. These differences deserve an explanation.

2\) Also, AN 8 and 9 responses are different from those in AN 1-4, especially as shown in [Figure 7](#fig7){ref-type="fig"}. The authors mention that AN8-9 may not express ETHR but may also lack the PBURS (BURS) receptors.

3\) I have problems with the notion that it is PBURS that plays a role in the control of ecdysis behaviors. It has been shown that the two subunits of bursicon (BURS and PBURS) heterodimerize spontaneously to the bioactive BURSICON if expressed together. Thus, the knock down of PBURS expression would prevent the production of a bioactive bursicon. In my opinion, it is simpler to assume that BURSICON has a feedback effect on the CCAP/BURSICON expressing AN neurons. Otherwise, the authors must show that in the early phases of ecdysis only PBURS is expressed, not BURS, and need to hypothesize a specific receptor for PBURS in these cells.

4\) The results indicate that not the entire GABA inhibition acts directly on the CCAP neurons but some input must be indirect. The authors also cite publications indicating that inhibitory influences may originate from the brain and/or sub-esophageal ganglion. I would like to emphasize that the Benjamin White lab has shown convincingly that two bursicon-expressing neurons in the SEG project into all abdominal neuromers and thus may have a direct effect on the release of bursicon from the ANs. It might be worthwhile to discuss whether the indirect GABA inhibition on these cells originates from the inhibition of the SEG neurons.

5\) The results provide convincing support that the peptidergic modulation of the CCAP neurons plays a critical role in the control of *Drosophila* ecdysis behavior. However, the ecdysis motor program is controlled by motor neurons and the authors show that the motor program as well as the alternating motor neuron activity was also severely disrupted in ETH RNAi puparium-free preparations. The authors should discuss the possible connections translating the activity of the AN-CCAP cells into the motor neuron pattern controlling the ecdysis.

6\) I would suggest using \* throughout to indicate statistically significant differences in the figures.

10.7554/eLife.19686.016

Author response

*Essential revisions:*

*There are a few concerns about controls (detailed in reviewer \#2 comments) and also some concerns about the complexity of the figures, particularly [Figure 4](#fig4){ref-type="fig"}. The manuscript focuses on two major questions: 1) Which mechanisms are responsible for producing the sequential activation of neuronal targets in response to a common ETH stimulus (latency responses), and 2) How does the amplitude of the CCAP response (Ca+ fluorescence) relate to the ecdysis motor pattern. These questions may help in the reorganization of the Figures. The authors may break up the results of their experimental approach in the figures more clearly with respect to answering these questions. The major concerns of reviewers \#2 and \#3 are listed below to guide in your revision.*

We agree with the "Major questions" identified above; however, since most of the manipulations we performed affected both the temporal organization of the response to ETH and its amplitude it would not be possible to present these 2 issues separately. Thus, we have not altered significantly the order of presentation of the results. However, we have followed the reviewers' advice and reorganized the figures to make life easier for the reader. A detail point-by-point response is provided below.

*Reviewer \#1:*

*Explain the statistical differences more fully in the text. Give exact p values.*

We have provided a more detailed description of the statistical differences in the legends of the relevant figures ([Figures 2](#fig2){ref-type="fig"}--[9](#fig9){ref-type="fig"}). Since there are so many comparisons we have not indicated the exact p values for each one; rather we have included a supplementary table that includes the exact p values for all statistical analyses performed ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}).

*Reviewer \#2:*

*There are two concerns that, if addressed, would improve this important study.*

*First, some critical experimental details are not adequately described in the manuscript. For example, the genotypes of the flies used in imaging experiments on RNAi manipulated brains should be clearly indicated either in the Results section or figure legend for every experiment. For example, it isn\'t clear from the description of the imaging experiments in [Figure 2](#fig2){ref-type="fig"} how GCaMP and the ETH-R RNAi constructs were independently driven in motor neurons and CCAP expressing neurons, respectively. Was the CCAP-LexA used to drive UAS-RNAi? If so, there does not seem to be a LexAop-ETH-RNAi element described. Or was a LexA used for motor neurons (in which case the driver and the LexAop-GCaMP should be described)? With the genotypes unclear, it is difficult to access how well controlled these experiments are. For example, how well have the authors controlled for the possibility of leaky RNAi expression in the imaging experiments? Some evidence that the genetic driver is required for the RNAi effects would strengthen these experiments. The authors should ensure that every fly line used in the study is described in the Methods section.*

We apologize for omitting these details. A description of the exact genotypes has now been added to the legends of the data figures ([Figures 1](#fig1){ref-type="fig"}--[8](#fig8){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Specifically with respect to [Figure 1](#fig1){ref-type="fig"} (= ex-[Figure 2](#fig2){ref-type="fig"}), motoneurons (MN) were imaged while knocking down ETH-R RNAi in CCAP neurons by driving ETH-R RNAi (and GCaMP) using a combined CCAP-GAL4+MN-GAL4 driver. The response of CCAP neurons is clearly distinguishable from MN activity. In addition, expressing ETH-R RNAi only in MN's had only a minor effect on ecdysis, affecting only the frequency of pre-ecdysial contractions, measured in intact puparium preparations ([Figure 1](#fig1){ref-type="fig"}). Thus, the GCaMP signal recorded using the CCAP-GAL4+MN-GAL4 driver reflects primarily (if not exclusively) the effects of knocking down ETH-R in CCAP neurons. This issue has been clarified in the legend to [Figure 1](#fig1){ref-type="fig"} (= ex-[Figure 2](#fig2){ref-type="fig"}).

With respect to possible leakage from UAS-RNAi constructs, we always tested (and reported) the relevant controls and did not detect any signs of leakage ([Figure 2](#fig2){ref-type="fig"}, for UAS-ETHR RNAi; [Figure 8](#fig8){ref-type="fig"}, UAS-GABA-RA, for GABA-RA). We have double-checked the Methods section to make sure it includes a description of all the fly line used in this study.

*Second, a reorganization of the figures would make this excellent manuscript more easily read. As organized, there are several highly related experiments that are spread over two or even three figures in the manuscript. The need to move between multiple figures to compare behavioral and physiological data for similar experimental manipulations makes the manuscript difficult to follow at times. For example, [Figure 4](#fig4){ref-type="fig"} does a nice job summarizing a great deal of data, but as presented it is a bit challenging to navigate. I would consider breaking these data up among the other figures. The reader would be better served if the ETH-R knockdown data in [Figure 4](#fig4){ref-type="fig"} were included in the current [Figure 3](#fig3){ref-type="fig"} and if the ETH dose response data were combined with the current [Figure 5](#fig5){ref-type="fig"}.*

We agree with this suggestion and have attempted to improve the readability of the manuscript. For this we have:

\- Inverted the order of the first two figures.

\- Included in a single figure the behavioral results obtained from intact puparium and puparium free preparations following a given manipulation; and, whenever space allowed it, these results have been presented together with the corresponding GCaMP results. Thus, [Figure 2](#fig2){ref-type="fig"} (ex-[Figure 1](#fig1){ref-type="fig"}) now includes both types of behavioral results obtained following ETH-R knockdown; [Figure 5](#fig5){ref-type="fig"} now includes both types of behavioral results obtained in the absence of EH function as well as the corresponding GCaMP activity of CCAP neurons in response to ETH; [Figure 6](#fig6){ref-type="fig"} includes both types of behavioral results obtained in *pburs* mutants, followed by [Figure 7](#fig7){ref-type="fig"}, which shows the responses of CCAP neurons in a *pburs* mutant background. Finally, [Figure 8](#fig8){ref-type="fig"} shows both types of behavioral results obtained when GABA-RA was knocked down in CCAP neurons as well as the corresponding GCaMP activity of the CCAP neurons in response to ETH.

\- We have also eliminated [Figure 4](#fig4){ref-type="fig"} as a main figure and added the relevant information in the text. We chose this option rather than breaking up [Figure 4](#fig4){ref-type="fig"} and adding parts of it to the relevant figures because for each genotype/manipulation we only report 2 pieces of information: the amplitude of the GCaMP response in CCAP neurons from segments TN3 and AN1-4 relative to control. This information has now been added to the relevant section of the Results (subsection "Role of ETH signaling in the activation of downstream peptidergic targets", third and fourth paragraphs; subsection "Influence of downstream peptides on the pattern of activation of CCAP neurons by ETH: role of Eclosion hormone", second paragraph and subsection "Influence of downstream peptides on the pattern of activation of ETH targets: role of PBURS"), and is therefore provided to the reader at the appropriate time. A similar approach was used to report the% responsiveness of CCAP neurons to ETH following different manipulations (e.g., subsection "Role of ETH signaling in the activation of downstream peptidergic targets", fourth paragraph). The contents of [Figure 4](#fig4){ref-type="fig"} has nevertheless been preserved but moved to [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

*Likewise, the authors might break up the comprehensive behavioral data shown in [Figure 1](#fig1){ref-type="fig"}, placing the various genetic manipulations alongside the imaging done on the same manipulations. This would allow the reader to move more easily from one figure to the next while reading the Results section.*

We have combined the behavioral results from intact puparium and puparium free preparations, as described above.

*Reviewer \#3:*

There are a few concerns that should be addressed:

*1) The figures indicate that the response of CCAP neurons in T3 to the diverse experimental manipulations differ from those in the abdominal neuromers 1-4 (AN1-4), see [Figure 3](#fig3){ref-type="fig"}, \# of spikes; [Figure 4](#fig4){ref-type="fig"}, amplitude of GCaMP response; [Figure 5](#fig5){ref-type="fig"} and [8](#fig8){ref-type="fig"}, \# of spikes; [Figure 9](#fig9){ref-type="fig"}, duration. These differences deserve an explanation.*

We agree with this reviewer that for several manipulations the response of TN3 neurons differs from that of abdominal neuromeres AN1-4. We don't understand the basis for such differences, which could be due to different levels of expression of ETHR, different wiring, etc. We have added text highlighting these segmental differences (subsection "Role of ETH signaling in the activation of downstream peptidergic targets", third paragraph).

*2) Also, AN 8 and 9 responses are different from those in AN 1-4, especially as shown in [Figure 7](#fig7){ref-type="fig"}. The authors mention that AN8-9 may not express ETHR but may also lack the PBURS (BURS) receptors.*

We agree that the responses of CCAP neurons in AN8 and AN9 differ from those seen in AN1-4. We do not know the basis for these differences but one factor that likely contributes is that the AN8 and AN9 CCAP neurons do nor express ETHR (Kim et al., 2006; Diao et al., 2016) and are thus insensitive to the direct actions of ETH. Yet, we appreciate the reviewer's comment that they likely also do not express the bursicon receptor since eliminating PBURS did not affect the (indirect) response of these neurons to these downstream hormones. We have added text mentioning this possibility (subsection "Influence of downstream peptides on the pattern of activation of ETH targets: role of PBURS").

*3) I have problems with the notion that it is PBURS that plays a role in the control of ecdysis behaviors. It has been shown that the two subunits of bursicon (BURS and PBURS) heterodimerize spontaneously to the bioactive BURSICON if expressed together. Thus, the knock down of PBURS expression would prevent the production of a bioactive bursicon. In my opinion, it is simpler to assume that BURSICON has a feedback effect on the CCAP/BURSICON expressing AN neurons. Otherwise, the authors must show that in the early phases of ecdysis only PBURS is expressed, not BURS, and need to hypothesize a specific receptor for PBURS in these cells.*

We agree with this reviewer that the bioassays used to measure the activity of BURS-BURS and PBURS-PBURS homodimers, and of BURS-PBURS heterodimers show that only the heterodimer (= bursicon) can activate the bursicon receptor in a heterologous assay and cause tanning in intact flies bioassay (Luo et al., 2005; Mendive et al., 2005). Nevertheless, there is the nagging fact that PBURS and BURS are not strictly co-expressed. Most notably, BURS is expressed in 1 pair of CCAP neurons in 8 abdominal segments whereas PBURS is only expressed in 4 of these. Thus, there are 4 segments in which CCAP neurons express only the BURS subunit of bursicon. Even though there is currently no activity associated with BURS-BURS homodimers it is difficult to escape the possibility that homodimers may be active in some context. Since we don't know which this activity may be, we chose to use the more conservative description of our results because, in our manipulations, all that we are really sure of is that we eliminated PBURS. Nevertheless, we do acknowledge in the text that the lack of PBURS causes a lack of bursicon (=BURS-PBURS heterodimer) ("Consistent with the findings of (Lahr et al., 2012), the lack of PBURS (and **thus of the heteromeric bursicon**; our emphasis here) in intact puparia caused a significant lengthening of ecdysis, with only 5/8 animals executing the behavior ([Figure 6A](#fig6){ref-type="fig"})."

*4) The results indicate that not the entire GABA inhibition acts directly on the CCAP neurons but some input must be indirect. The authors also cite publications indicating that inhibitory influences may originate from the brain and/or sub-esophageal ganglion. I would like to emphasize that the Benjamin White lab has shown convincingly that two bursicon-expressing neurons in the SEG project into all abdominal neuromers and thus may have a direct effect on the release of bursicon from the ANs. It might be worthwhile to discuss whether the indirect GABA inhibition on these cells originates from the inhibition of the SEG neurons.*

We are well aware of these studies (Luan et al., 2006; and Peabody et al., 2009), yet they apply to the control of bursicon release and wing expansion, both of which take place *after* adult emergence (which corresponds to adult ecdysis); they are thus not relevant to pupal ecdysis, where genetic evidence indicates that bursicon plays a role in the *execution* of ecdysis itself (Lahr et al., 2012). Although the inhibitory SEG neurons described in these reports and mentioned by this reviewer could contribute the delay in expression of the ecdysial phase of ecdysis, there is no direct evidence that this is the case. We did not cite this work because the control of ecdysis differs between pupal and adult ecdysis (e.g., the role of bursicon changes dramatically). Thus we do not feel comfortable extrapolating to pupal ecdysis neuronal elements that control adult ecdysis, especially if they regulate events that are expressed *after* adult ecdysis.

Prior to our finding the only available information was that decapitation of the animal after ETH release significantly reduced the latency to ecdysis. However, given the radical nature of this manipulation it would be difficult to argue convincingly that this inhibition was mediated by an inhibition specifically originating from the brain or subesophageal ganglion. Here we have advanced our understanding of the nature of this inhibition by showing that at least part of the delay in activation of CCAP neurons is due to a direct inhibition of CCAP neurons by GABA. Future studies will attempt to identify the relevant GABA-ergic neurons, and determine whether they respond directly or indirectly to ETH.

*5) The results provide convincing support that the peptidergic modulation of the CCAP neurons plays a critical role in the control of Drosophila ecdysis behavior. However, the ecdysis motor program is controlled by motor neurons and the authors show that the motor program as well as the alternating motor neuron activity was also severely disrupted in ETH RNAi puparium-free preparations. The authors should discuss the possible connections translating the activity of the AN-CCAP cells into the motor neuron pattern controlling the ecdysis.*

Some of the players that transduce ETH actions within the CNS have been identified. They are neurons that express the "A" isoform of the ETH receptor (ETH-RA) and consist of peptidergic neurons that express kinin, FMRFamide, EH, CCAP (in combination with MIP and bursicon). In addition there are several dozen neurons that express ETH-RB, whose identity is currently unknown. Yet it is unlikely that motoneurons are relevant ETH targets. Indeed, expressing ETHR RNAi in motoneurons had, at most, a modest effect on ecdysis behavior: no effect was detected on ecdysis behavior monitored in intact preparations, and only an effect on ecdysis frequency could be detected in puparium free preparations ([Figure 2B](#fig2){ref-type="fig"}). Thus it is unlikely that motoneurons are direct targets of ETH. Rather it is possible that peptide downstream of ETH are involved in directly controlling or modulating the ecdysis motor programs. Preliminary evidence indicates that CCAP may play an important role, because the timing of GCaMP activity in motoneurons follows closely the pattern of GCaMP activity of CCAP neurons. A sentence to this effect has been added to the Discussion (first paragraph).

*6) I would suggest using \* throughout to indicate statistically significant differences in the figures.*

We appreciate this suggestion and have used "\*" for comparisons that are between experimental vs. control (e.g., [Figures 2](#fig2){ref-type="fig"}, [5](#fig5){ref-type="fig"}, [6](#fig6){ref-type="fig"}, [7](#fig7){ref-type="fig"}, [8A-B,](#fig8){ref-type="fig"} and [9C](#fig9){ref-type="fig"}). However, for cases where we made multiple comparisons test we think it is more appropriate to use letters (a different letter for statistically different groups). The results of such comparisons can be complex and using "\*" and brackets would unnecessarily clutter the figures.

[^1]: Institut de Neurobiologie Alfred Fessard, Gif-sur-Yvette Cedex, France.

[^2]: Department of Neurobiology / Animal Physiology, University of Cologne, Köln, Germany.
